Also known as: STZ; Streptozocin; Zanosar
Streptozotocin is a naturally occurring nitrosourea cytotoxic antibiotic used primarily for treatment of metastatic islet cell carcinoma of the pancreas. Mediocon Inc supplies pharmaceutical-grade Streptozotocin conforming to IP / BP / EP / USP specifications.
It selectively destroys insulin-producing beta cells of the pancreas and is widely used as a research tool to induce diabetes in animal models. It also has antineoplastic properties used in oncology.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |